These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2869318)

  • 1. HTLV-III seroconversion associated with heat-treated factor VIII concentrate.
    White GC; Matthews TJ; Weinhold KJ; Haynes BF; Cromartie HL; McMillan CW; Bolognesi DP
    Lancet; 1986 Mar; 1(8481):611-2. PubMed ID: 2869318
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroconversion to HTLV-III haemophiliac given heat-treated factor VIII concentrate.
    van den Berg W; ten Cate JW; Breederveld C; Goudsmit J
    Lancet; 1986 Apr; 1(8484):803-4. PubMed ID: 2870298
    [No Abstract]   [Full Text] [Related]  

  • 3. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France.
    Mathez D; Leibovitch J; Sultan Y; Maisonneuve P
    N Engl J Med; 1986 Jan; 314(2):118-9. PubMed ID: 3079879
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transmission of the human immunodeficiency virus by a dry heat-treated Factor VIII concentrate?].
    Weisser J
    Klin Padiatr; 1988; 200(5):375-9. PubMed ID: 3141670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III.
    McGrath KM; Thomas KB; Herrington RW; Turner PJ; Taylor L; Ekert H; Schiff P; Gust ID
    Med J Aust; 1985 Jul; 143(1):11-3. PubMed ID: 2989666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.
    Goedert JJ; Sarngadharan MG; Eyster ME; Weiss SH; Bodner AJ; Gallo RC; Blattner WA
    Blood; 1985 Feb; 65(2):492-5. PubMed ID: 2981592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
    Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX
    Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired immunodeficiency syndrome, hepatitis, and haemophilia.
    Jones P
    Br Med J (Clin Res Ed); 1983 Dec; 287(6407):1737-8. PubMed ID: 6416569
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS and haemophilia.
    Carr R
    Biomed Pharmacother; 1985; 39(7):347-50. PubMed ID: 3006817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat-treated NHS factor VIII concentrate in the United Kingdom--a preliminary study.
    Colvin BT; Ainsworth M; Machin SJ; Mackie IJ; Smith JK; Winkelman L; Haddon ME
    Clin Lab Haematol; 1986; 8(2):85-92. PubMed ID: 3015481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acquired immunodeficiency syndrome in persons with hemophilia.
    Levine PH
    Ann Intern Med; 1985 Nov; 103(5):723-6. PubMed ID: 2996407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
    Shannon BT; Roach J; Cheek-Luten M; Ruymann FB
    Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-III serology in hemophilia: relationship with immunologic abnormalities.
    Gill JC; Menitove JE; Anderson PR; Casper JT; Devare SG; Wood C; Adair S; Casey J; Scheffel C; Montgomery RR
    J Pediatr; 1986 Apr; 108(4):511-6. PubMed ID: 3083075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence of HIV transmission after long-term follow-up of haemophiliacs treated with heat-treated factor VIII concentrate of American origin.
    Berntorp E
    Lancet; 1987 Aug; 2(8553):283. PubMed ID: 2886754
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
    Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
    Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate.
    van der Meer J; Daenen S; van Imhoff GW; de Wolf JT; Halie MR
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1049. PubMed ID: 3008906
    [No Abstract]   [Full Text] [Related]  

  • 18. Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.
    Ludlam CA; Tucker J; Steel CM; Tedder RS; Cheingsong-Popov R; Weiss RA; McClelland DB; Philp I; Prescott RJ
    Lancet; 1985 Aug; 2(8449):233-6. PubMed ID: 2862416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T
    AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV seroconversion in Swedish haemophiliacs: relation to type and dosage of factor concentrate.
    Berntorp E; Hansson BG; Böttiger B; Jarevi G; Wedbäck A; Nordenfelt E; Nilsson IM
    Eur J Haematol; 1987 Mar; 38(3):256-60. PubMed ID: 3109938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.